The urinogenital microbiome, encompassing the urinary and reproductive systems, plays a crucial role in maintaining health and preventing infections. Probiotics and prebiotics offer promising avenues for supporting this delicate microbial balance. Probiotics, such as certain strains of lactobacilli, can colonize the urinary and genital tracts, promoting a healthy microbiota and inhibiting the growth of pathogenic bacteria. Prebiotics, on the other hand, provide nourishment to beneficial bacteria already present in the microbiome, aiding in their growth and activity. Together, probiotics and prebiotics contribute to a balanced urinogenital microbiome, potentially reducing the risk of urinary tract infections, bacterial vaginosis, and other related conditions. Further research is needed to optimize their use and explore their full potential in maintaining urogenital health.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India